2014
Cataract formation following vitreoretinal procedures
Feng H, Adelman RA. Cataract formation following vitreoretinal procedures. Clinical Ophthalmology 2014, Volume 8: 1957-1965. PMID: 25284982, PMCID: PMC4181740, DOI: 10.2147/opth.s68661.Peer-Reviewed Original ResearchPars plana vitrectomyScleral bucklePneumatic retinopexyVitreoretinal proceduresPostoperative cataractCataract extractionGauge pars plana vitrectomySmall-gauge pars plana vitrectomyYale Eye CenterRetrospective observational studyMain outcome measuresNuclear sclerotic cataractPercentage of eyesSignificant differencesLens statusSurgical eyesPostoperative dataConsecutive patientsPlana vitrectomyIntraocular surgeryMedical recordsObservational studyInclusion criteriaOutcome measuresEye Center
2011
The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab
Lee ST, Adelman RA. The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab. Journal Of Ocular Pharmacology And Therapeutics 2011, 27: 611-614. PMID: 21810026, DOI: 10.1089/jop.2011.0045.Peer-Reviewed Original ResearchConceptsRecurrent central serous chorioretinopathyMean central macular thicknessCentral macular thicknessCentral serous chorioretinopathyPreinjection visual acuityVisual acuityOptical coherence tomographyIntravitreal bevacizumabSerous chorioretinopathyTreatment optionsLow-risk treatment optionYale Eye CenterIntravitreal bevacizumab injectionRetrospective case seriesEffective treatment optionLong-term efficacySub-retinal fluidNumber of injectionsFluorescein angiography imagingBevacizumab injectionRecurrent diseaseMacular thicknessMonth 3Month 6Case series